Searched for
RONAPREVE
COVID antiviral Molnupiravir to be tested in RECOVERY trial on hospitalised patientsThe RECOVERY Trial was launched as an emergency response in March 2020 and has so far discovered three effective treatments for COVID-19 - ...- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- European shares inch up in thin tradingThe pan-European STOXX 600 rose 0.2% following a mixed session for Asian shares.
- Pfizer's pill is the latest COVID treatment to show promise. Here are some moreAccording to Pfizer's trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression i...
- Amid spike in cases, EU to shortly approve first COVID antibody drugs - sourcesThe European Medicines Agency (EMA) will this week give the green light to the treatment developed by U.S. biotech firm Regeneron and Swiss...
- EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisationTill now, only Gilead's antiviral, remdesivir, is the only COVID-19 treatment that has been approved for use in EU. Japanese regulators app...
- UK to roll out life-saving COVID-19 treatment which was given to Donald TrumpThe treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
- Japan becomes first country to approve Ronapreve Covid treatmentThe approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid...
Load More